21Vianet Partners with Microsoft and Tencent to Deliver Office Online
May 19, 2017 12:02 pm UTC| Business
BEIJING, May 19, 2017 -- 21Vianet Group, Inc. (NASDAQ:VNET) (“21Vianet or the “Company”) today announced that it has partnered with Microsoft and Tencent to launch Microsoft Office Online. In partnering with Tencent...
21Vianet Partners with Microsoft and Tencent to Deliver Office Online
May 19, 2017 12:02 pm UTC| Business
BEIJING, May 19, 2017 -- 21Vianet Group, Inc. (NASDAQ:VNET) (“21Vianet or the “Company”) today announced that it has partnered with Microsoft and Tencent to launch Microsoft Office Online. In partnering with Tencent...
CareDx to Announce First Quarter 2017 Preliminary Financial Results on May 22, 2017
May 19, 2017 12:02 pm UTC| Business
BRISBANE, Calif., May 19, 2017 -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for...
CareDx to Announce First Quarter 2017 Preliminary Financial Results on May 22, 2017
May 19, 2017 12:02 pm UTC| Business
BRISBANE, Calif., May 19, 2017 -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for...
CareDx to Announce First Quarter 2017 Preliminary Financial Results on May 22, 2017
May 19, 2017 12:02 pm UTC| Business
BRISBANE, Calif., May 19, 2017 -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for...
May 19, 2017 12:02 pm UTC| Business
NEW YORK, May 19, 2017 -- Avenue Therapeutics, Inc. (“Avenue”), a Fortress Biotech (NASDAQ:FBIO) Company, today announced that Notice of Allowance has now been received from the U.S. Patent and Trademark Office (USPTO)...
May 19, 2017 12:02 pm UTC| Business
NEW YORK, May 19, 2017 -- Avenue Therapeutics, Inc. (“Avenue”), a Fortress Biotech (NASDAQ:FBIO) Company, today announced that Notice of Allowance has now been received from the U.S. Patent and Trademark Office (USPTO)...